Notable entries related to cancer treatment were: 1) technetium (99mTc) arcitumomab (DB00113), a technetium-labeled carcinoembryonic antigen (CEA) monoclonal antibody used in the treatment of CEA-overexpressing colorectal cancers; 2) natural human interferon alfa and recombinant human interferon alfa-2b (DB05258 and DB00105), used to treat viral infections and blood cancers, including melanoma. This evidence concerns the gene CEACAM5 and cancer.